Without a doubt, if AMBS was not on the OTC, all o
Post# of 30028
I think that we won't a large surplus of new investors until we have revenue. I love where we are. As soon as we announce revenue, we're going to dramatically increase. Just my opinion though.
However, what is our situation as it relates to cash on hand? It seems like we're getting close to needing more. I haven't heard any plan on how that will happen. Maybe I missed it? What are our options?